Correction to: Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

被引：0
|
作者：
George G. Zhanel
Courtney K. Lawrence
Heather Adam
Frank Schweizer
Sheryl Zelenitsky
Michael Zhanel
Philippe R. S. Lagacé-Wiens
Andrew Walkty
Andrew Denisuik
Alyssa Golden
Alfred S. Gin
Daryl J. Hoban
Joseph P. Lynch
James A. Karlowsky
机构：
[1] University of Manitoba,Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine
[2] University of Manitoba,College of Pharmacy
[3] University of Manitoba,Department of Chemistry, Faculty of Science
[4] Winnipeg Health Sciences Centre,Department of Medicine
[5] Winnipeg Health Sciences Centre,Department of Pharmacy
[6] Diagnostic Services Manitoba,Division of Pulmonary, Critical Care, Allergy and Clinical Immunology
[7] The David Geffen School of Medicine at UCLA,undefined
来源：
Drugs | 2018年 / 78卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Section heading 5.2, which currently reads 5.2 Meropenem–Relebactam.
引用
收藏
页码：787 / 787
相关论文
共 50 条
  • [1] Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
    George G. Zhanel
    Courtney K. Lawrence
    Heather Adam
    Frank Schweizer
    Sheryl Zelenitsky
    Michael Zhanel
    Philippe R. S. Lagacé-Wiens
    Andrew Walkty
    Andrew Denisuik
    Alyssa Golden
    Alfred S. Gin
    Daryl J. Hoban
    Joseph P. Lynch
    James A. Karlowsky
    Drugs, 2018, 78 : 65 - 98
  • [2] Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
    Zhanel, George G.
    Lawrence, Courtney K.
    Adam, Heather
    Schweizer, Frank
    Zelenitsky, Sheryl
    Zhanel, Michael
    Lagace-Wiens, Philippe R. S.
    Walkty, Andrew
    Denisuik, Andrew
    Golden, Alyssa
    Gin, Alfred S.
    Hoban, Daryl J.
    Lynch, Joseph P., III
    Karlowsky, James A.
    DRUGS, 2018, 78 (01) : 65 - 98
  • [3] Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations (vol 78, pg 65, 2018)
    Zhanel, George G.
    Lawrence, Courtney K.
    Adam, Heather
    Schweizer, Frank
    Zelenitsky, Sheryl
    Zhanel, Michael
    Lagace-Wiens, Philippe R. S.
    Walkty, Andrew
    Denisuik, Andrew
    Golden, Alyssa
    Gin, Alfred S.
    Hoban, Daryl J.
    Lynch, Joseph P., III
    Karlowsky, James A.
    DRUGS, 2018, 78 (07) : 787 - 787
  • [4] Efficacy and safety of novel carbapenem-β-lactamase inhibitor combinations: imipenem-cilastatin/relebactam results from randomized controlled trials
    Yang, Qingxin
    Yang, Yanqiu
    He, Rong
    Yu, Bin
    Zhong, Yueling
    Lin, Fei
    FRONTIERS IN MEDICINE, 2023, 10
  • [5] Meropenem/Vaborbactam, the First Carbapenem/-Lactamase Inhibitor Combination
    Cho, Jonathan C.
    Zmarlicka, Monika T.
    Shaeer, Kristy M.
    Pardo, Joe
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (08) : 769 - 779
  • [6] Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
    Mansour, Hanine
    Ahmad El Ouweini
    Chahine, Elias B.
    Karaoui, Lamis R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (08) : 674 - 683
  • [7] Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
    Bhowmick, Tanaya
    Weinstein, Melvin P.
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (04) : 757 - 767
  • [8] Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
    Tanaya Bhowmick
    Melvin P. Weinstein
    Infectious Diseases and Therapy, 2020, 9 : 757 - 767
  • [9] Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens
    Biagi, M.
    Shajee, A.
    Vialichka, A.
    Jurkovic, M.
    Tan, X.
    Wenzler, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
  • [10] Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae
    Young R. Lee
    Nathaniel T. Baker
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1411 - 1419
12345